Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Madrona Venture Group, LLC (CIK 1887785) reported $22.1M across 3 reported positions in its SEC 13F filing for 2025-12-31. Largest positions: NAUT ($11.7M, 53.24%), PATH ($10.0M, 45.16%), DNA ($353,000, 1.60%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | NAUT | NAUTILUS BIOTECHNOLOGY INC | $11.7M | 53.24% | 6.0M | Hold |
| 2 | PATH | UIPATH INC | $10.0M | 45.16% | 607,673 | Hold |
| 3 | DNA | GINKGO BIOWORKS HOLDINGS, INC. | $353,000 | 1.60% | 42,430 | Hold |
Source: SEC Form 13F filings · as of 2025-12-31